Home

UNA S RYAN

CIK 1255349 · President & CEO · last filed 2026-06-24

UNA S RYAN is a President & CEO who has filed 39 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RNXT, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$49.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $93.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$93.9K

Companies

5

Total Filings

39

Lifetime Open-Market Net

$49.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RNXT Director 80,959 $1.16 $93.9K $0 7 2026-06-24
QNCX Director — $30.65 — $0 3 2025-06-06
Quince Therapeutics, Inc. (CRTX) Delisted Director 2,875 $1.95 $5.6K $48.9K 4 2022-06-09
ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted Director 51,845 — — $562 22 2017-05-11
Celldex Therapeutics, Inc. (AVAND) Delisted President & CEO — — — $0 1 2008-03-11

Recent Filings

39 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 RNXT Other (J) +97,165 $276.5K EDGAR
2025-10-02 RNXT Grant (A) — $0 EDGAR
2025-06-06 QNCX Grant (A) — $0 EDGAR
2024-10-02 RNXT Grant (A) — $0 EDGAR
2024-06-07 QNCX Grant (A) — $0 EDGAR
2023-10-02 RNXT Grant (A) — $0 EDGAR
2023-05-26 QNCX Grant (A) — $0 EDGAR
2022-10-04 RNXT Grant (A) — $0 EDGAR
2022-06-09 Quince Therapeutics, Inc. (CRTX) Delisted Grant (A) — $0 EDGAR
2022-03-14 RNXT Grant (A) — $0 EDGAR
Showing 1–10 of 39
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.